Tag Archives: Stomach

ASCO: Merck details Keytruda’s second stomach cancer slip

CHICAGO—Last month, Merck revealed that its Keytruda immunotherapy had run into more trouble in stomach cancer, a disease that’s given it difficulty in the past. And it shared the details of that stumble Saturday. In previously untreated patients with advanced gastric or gastroesophageal junction cancer whose tumors bore biomarker PD-L1, adding Keytruda to chemo failed to… Read More »